CUT MIX 150

Dragon Pharma Cut Mix 150 – Advanced Cutting Blend

Cut Mix 150 by Dragon Pharma is a fast-acting cutting blend combining three potent short esters: Drostanolone Propionate (50 mg), Testosterone Propionate (50 mg), and Trenbolone Acetate (50 mg) per mL. This combination is designed for experienced users aiming to enhance muscle definition, maintain lean mass, and support a harder, more conditioned physique during cutting phases.

Thanks to its short ester profile, Cut Mix 150 delivers rapid onset of action with greater control over blood levels, making it a preferred option for shorter cycles and contest preparation phases.

What Makes It Different?

• ✔ Supports lean, dry muscle retention during calorie deficits
• ✔ Enhances muscle hardness, density, and vascular appearance
• ✔ Promotes strength and performance during cutting cycles
• ✔ Fast-acting esters allow quicker adjustments and clearance
• ✔ Well-suited for advanced users and short-duration protocols

Product Details

Dosage & Usage Guidelines

Administration Profile

• ✔ Injectable oily solution
• ✔ Fast-acting short ester blend
• ✔ Typically administered frequently to maintain stable levels

Because all compounds in Cut Mix 150 are short esters, injections are typically performed every other day or every third day to help maintain more consistent blood levels and performance effects.

Typical Use Context

Cut Mix 150 is generally used during cutting or recomposition phases, where the goal is to preserve lean muscle while improving overall conditioning, hardness, and visual definition.

This blend is most commonly utilized by experienced users due to the inclusion of Trenbolone Acetate, which can significantly impact recovery, performance, and overall training intensity.

Example Usage Approach

• Cycle duration: 4–6 weeks (short ester protocol)
• Typical range: 100–150 mg per injection
• Injection frequency: Every other day (EOD) or every 3 days (E3D)
• Common combinations: Winstrol for added dryness and strength
• Estrogen management: Arimidex or Femara may be used depending on individual response
• Prolactin management: Dostinex (Cabergoline) may be considered if needed

Stack Suggestions

Advanced Cutting Stack Example:

• Weeks 1–6: Cut Mix 150 (short ester protocol)
• Weeks 1–6: Winstrol (oral or injectable)
• Support compounds: Aromatase inhibitor + optional prolactin management

Post-Cycle Therapy (PCT)

• Common approach: Clomid-based protocol (4 weeks)
• Additional support: May include Nolvadex depending on individual strategy

Warnings & Side Effects

• Not recommended for beginners due to potency
• May contribute to estrogen-related and androgenic side effects
• Trenbolone component may impact sleep, mood, and cardiovascular strain
• Regular bloodwork is strongly advised to monitor hormone levels
• Follow proper sterile injection practices

Batch-Tested & Verified Lab Results

Lab file

cut-mix-lab-test-2026-03-25

Independent analytical testing confirms that this batch of Cut Mix 150 delivers consistent potency across all three active compounds. The measured results closely align with the labeled 150 mg formulation, demonstrating accurate dosing and reliable manufacturing standards.

Test Date

2026-03-25

Batch Number

#CA2Q17

Total Measured

158.41 mg/mL

Compound Breakdown

Drost P: 47.87 mg
Test P: 51.65 mg
Tren A: 48.89 mg

COA summary: potency verified across all compounds, consistent with labeled profile. No irregularities detected within standard assay variance.

COA Verified

Shipping & Product Authenticity

What to Expect

• ✔ Orders are processed after payment confirmation
• ✔ USA warehouse options provide faster domestic delivery when selected
• ✔ International shipments include tracking, though updates may be limited during transit
• ✔ Orders may ship from multiple warehouses depending on stock availability
• ✔ Free reshipment is offered if a package is not delivered within 30 days

For complete delivery details, tracking updates, and reshipment terms, please see our Shipping Info page.

Storage

Store at controlled room temperature (15–25°C / 59–77°F) in a dry place, protected from excessive heat, moisture, and direct light. Avoid repeated temperature fluctuations, as stable conditions help preserve the integrity of the oily solution and carrier system.

Keep the vial in its original packaging until use. Do not freeze. Always inspect the solution before administration and avoid use if it appears cloudy, discolored, or contains visible particulate matter, or if the vial or seal is damaged.

Handle using proper sterile injection practices and keep out of reach of children.

Frequently Asked Questions